Isomorphic Labs Targets $2B Round, Thrive Capital And Alphabet To Lead Investment - Alphabet (NASDAQ:GOOG

Read full story on benzinga.com
Share
Isomorphic Labs Targets $2B Round, Thrive Capital And Alphabet To Lead Investment - Alphabet (NASDAQ:GOOG
AI disclosure

Summary

Thrive Capital and Alphabet are leading new financing for Isomorphic Labs, the AI-powered drug discovery company.

Original reporting

Open original source

Related coverage

Read full article on benzinga.com